Russia is the first nation to approve Novartis' MS drug Gilenia

09/12/2010 | Reuters

Russian health authorities approved Gilenia, Novartis' treatment for relapsing multiple sclerosis. The company is expected to obtain FDA approval of the drug this month.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN